Vitamin D Research

back to research menu

Autoimmune Illness

• Vitamin d and autoimmune disease.Acta Med Indones. 2007 Oct–Dec;39(3):133–41.
• Modulatory effects of 1,25‑dihydroxyvitamin d3 on human B cell differentiation.J Immunol. 2007 Aug 1;179(3):1634–47.
• 1,25‑dihydroxyvitamin D(3) reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.J Neurosci Res. 2007 Jun 28;.
• Activation of the human immunodeficiency virus type I long terminal repeat by 1alpha,25‑dihydroxyvitamin D3.J Mol Endocrinol. 2007 Jun;38(6):587–601.
• Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL‑628 (elocalcitol).J Steroid Biochem Mol Biol. 2007 Jan 19;.
• Favourable and unfavourable effects of exposure to sunlight.Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
• Coeliac disease and risk of tuberculosis: a population based cohort study.Thorax. 2007 Jan;62(1):23–8. Epub 2006 Oct 17.
• IL‑10 signaling is essential for 1,25‑dihydroxyvitamin D3‑mediated inhibition of experimental autoimmune encephalomyelitis.J Immunol. 2006 Nov 1;177(9):6030–7.
• Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation?Prog Biophys Mol Biol. 2006 Sep;92(1):140–9. Epub 2006 Feb 28. Review.
• Vitamin D physiology.Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Epub 2006 Feb 28. Review.
• Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease.Prog Biophys Mol Biol. 2006 Sep;92(1):60–4. Epub 2006 Feb 28. Review.
• Interaction among vitamin D(3) analogue KH 1060, TNF‑alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.Int Immunopharmacol. 2006 Jul;6(7):1083–92. Epub 2006 Feb 23.
• A potential role for vitamin D on HIV infection?Nutr Rev. 2006 May;64(5 Pt 1):226–33. Review.
• 1,25 dihydroxyvitamin D3 modulates JAK‑STAT pathway in IL‑12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis.J Neurosci Res. 2006 Mar 17;
• Vitamin D deficiency in systemic lupus erythematosus.Autoimmun Rev. 2006 Feb;5(2):114–7. Epub 2005 Jun 21. Review.
• Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis.Rheumatol Int. 2006 Jan 31;:1–8
• Immunoregulation by 1,25‑dihydroxyvitamin D3: basic concepts.J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):93–101. Epub 2005 Jul 19. Review.
• D‑hormone and the immune system.J Rheumatol Suppl. 2005 Sep;76:11–20.
• Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus.Autoimmunity. 2005 Sep;38(6):439–44.
• Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):426–31.
• Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
• Vitamin D status, 1,25‑dihydroxyvitamin D3, and the immune system.Am J Clin Nutr. 2004 Dec;80(6 Suppl):1717S–20S. Review.
• Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease PrevalenceExperimental Biology and Medicine 229:1136–1142 (2004). Review.
• Osteopenia in HIV‑infected women prior to highly active antiretroviral therapy.J Infect. 2003 May;46(4):221–7.
• The immunological functions of the vitamin D endocrine system.Cell Mol Biol (Noisy‑le‑grand). 2003 Mar;49(2):277–300. Review.
• Ultraviolet radiation and autoimmune disease: insights from epidemiological research.Toxicology. 2002 Dec 27;181–182:71–8. Review.
• Vitamin D status in children, adolescents, and young adults with Crohn disease.Am J Clin Nutr. 2002 Nov;76(5):1077–81.
• The coming of age of 1,25‑dihydroxyvitamin D(3) analogs as immunomodulatory agents.Trends Mol Med. 2002 Apr;8(4):174–9. Review.
• Vitamin D: its role and uses in immunology.FASEB J. 2001 Dec;15(14):2579–85. Review.
• Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.J Rheumatol. 2001 Nov;28(11):2535–9.
• Bone density and 25‑OH vitamin D serum level in patients with systemic lupus erythematosus.Z Rheumatol. 2001 Oct;60(5):352–8.
• Association of vitamin D receptor genotypes with early onset rheumatoid arthritis.Eur J Immunogenet. 2001 Feb;28(1):89–93.
• High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease.Endocr J. 2001 Feb;48(1):63–9.
• Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?Experimental Biology and Medicine 223:230–233 (2000). Review.
• Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients.Clin Exp Rheumatol. 1999 Jul–Aug;17(4):453–6.
• Severe deficiency of 1,25‑dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis.J Clin Endocrinol Metab. 1998 Nov;83(11):3832–8.
• Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis.Calcif Tissue Int. 1998 Mar;62(3):193–8.
• Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low‑dose corticosteroids in patients with rheumatoid arthritis. A randomized, double‑blind, placebo‑controlled trial.Ann Intern Med. 1996 Dec 15;125(12):961–8.
• Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25‑hydroxyvitamin D3 in patients with systemic lupus erythematosus.Clin Rheumatol. 1995 Jul;14(4):397–400.
• Effects of vitamin D3 and cyclosporin A on HgCl2‑induced autoimmunity in Brown Norway rats.Nephrol Dial Transplant (1995) 10: 2020–2026.
• Low serum vitamin D metabolites in women with rheumatoid arthritis.Scand J Rheumatol. 1993;22(4):172–7.
• Abnormal vitamin D3 metabolism in patients with primary Sjogren's syndrome.Ann Rheum Dis. 1990 Sep;49(9):682–4.
• Serum concentration of vitamin D metabolites in rheumatoid arthritis.Clin Rheumatol. 1987 Jun;6(2):238–43.
• Reduced serum 1,25‑(OH)2 vitamin D3 levels in prednisone‑treated adolescents with systemic lupus erythematosus.Acta Paediatr Scand. 1979 Jan;68(1):109–11.

back to research menu